|

hUC-MSCs treatment （Double dose） Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1/2: 1

Top Sponsors

  • Shenzhen Beike Bio-Technology Co., Ltd.1

Indications

  • Systemic Lupus Erythematosus (SLE)1
  • Lupus1

Other1 trial

Treatment of Systemic Lupus Erythematosus With Human Umbilical Cord Mesenchymal Stem Cells
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.